These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27716397)

  • 1. A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator.
    Bhattacharyya S; Wang W; Graham LV; Varga J
    Arthritis Res Ther; 2016 Oct; 18(1):216. PubMed ID: 27716397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
    Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
    Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
    Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.
    Wei J; Ghosh AK; Sargent JL; Komura K; Wu M; Huang QQ; Jain M; Whitfield ML; Feghali-Bostwick C; Varga J
    PLoS One; 2010 Nov; 5(11):e13778. PubMed ID: 21072170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.
    Bhattacharyya S; Kelley K; Melichian DS; Tamaki Z; Fang F; Su Y; Feng G; Pope RM; Budinger GR; Mutlu GM; Lafyatis R; Radstake T; Feghali-Bostwick C; Varga J
    Am J Pathol; 2013 Jan; 182(1):192-205. PubMed ID: 23141927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.
    Wang W; Bale S; Wei J; Yalavarthi B; Bhattacharyya D; Yan JJ; Abdala-Valencia H; Xu D; Sun H; Marangoni RG; Herzog E; Berdnikovs S; Miller SD; Sawalha AH; Tsou PS; Awaji K; Yamashita T; Sato S; Asano Y; Tiruppathi C; Yeldandi A; Schock BC; Bhattacharyya S; Varga J
    Nat Commun; 2022 Oct; 13(1):6358. PubMed ID: 36289219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.
    Tomcik M; Palumbo-Zerr K; Zerr P; Sumova B; Avouac J; Dees C; Distler A; Becvar R; Distler O; Schett G; Senolt L; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):609-16. PubMed ID: 25603829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
    Wei J; Fang F; Lam AP; Sargent JL; Hamburg E; Hinchcliff ME; Gottardi CJ; Atit R; Whitfield ML; Varga J
    Arthritis Rheum; 2012 Aug; 64(8):2734-45. PubMed ID: 22328118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
    Wei J; Ghosh AK; Chu H; Fang F; Hinchcliff ME; Wang J; Marangoni RG; Varga J
    Arthritis Rheumatol; 2015 May; 67(5):1323-34. PubMed ID: 25707573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
    Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
    Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
    Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
    Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
    Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
    J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
    Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
    Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
    Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
    Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.